Weilenmann, Daniel

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 26.

Journal Article

Iglesias, Juan F; Roffi, Marco; Losdat, Sylvain; Muller, Olivier; Degrauwe, Sophie; Kurz, David J; Haegeli, Laurent; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Cook, Stéphane; Cuculi, Florim; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial. Lancet, 402(10416), pp. 1979-1990. Elsevier 10.1016/S0140-6736(23)02197-9

Häner, Jonas D; Rohla, Miklos; Losdat, Sylvain; Iglesias, Juan F; Muller, Olivier; Eeckhout, Eric; Kurz, David; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Roffi, Marco; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials. American Heart Journal, 263, pp. 73-84. Elsevier 10.1016/j.ahj.2023.05.004

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial. Catheterization and cardiovascular interventions, 101(4), pp. 687-700. Wiley-Blackwell 10.1002/ccd.30600

Wagener, Max; Boeddinghaus, Jasper; Gaemperli, Oliver; Räber, Lorenz; Nietlispach, Fabian; Meier, Pascal; Muller, Olivier; Weilenmann, Daniel; Jeger, Raban (2022). Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey. Journal of clinical medicine, 11(24) MDPI 10.3390/jcm11247459

Iglesias, Juan F; Heg, Dik; Roffi, Marco; Degrauwe, Sophie; Tüller, David; Muller, Olivier; Brinkert, Miriam; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2022). Five-year outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with acute coronary syndrome: A subgroup analysis of the BIOSCIENCE trial. Cardiovascular revascularization medicine, 34, pp. 3-10. Elsevier 10.1016/j.carrev.2021.02.008

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Heg, Dik; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas (2021). Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment-elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial. International journal of cardiology, 334, pp. 37-41. Elsevier 10.1016/j.ijcard.2021.04.034

Van Belle, Eric; Teles, Rui C; Pyxaras, Stylianos A; Kalpak, Oliver; Johnson, Thomas William; Barbash, Israel Moshe; De Luca, Giuseppe; Kostov, Jorgo; Parma, Radoslaw; Vincent, Flavien; Brugaletta, Salvatore; Debry, Nicolas; Toth, Gabor G; Ghazzal, Ziyad; Deharo, Pierre; Milasinovic, Dejan; Kaspar, Klaus; Saia, Francesco; Mauri, Josepa; Kammler, Jürgen; ... (2021). EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology. EuroIntervention, 17(1), pp. 23-31. Europa Digital & Publishing 10.4244/EIJ-D-18-00448

Wagener, Max; Twerenbold, Raphael; Cook, Stéphane; Gaemperli, Oliver; Meier, Pascal; Muller, Olivier; Nietlispach, Fabian; Raeber, Lorenz; Weilenmann, Daniel; Jeger, Raban (2021). Coronary and structural heart interventions in Switzerland 2019. Swiss medical weekly, 151, w20495. EMH Media 10.4414/smw.2021.20495

Pilgrim, Thomas; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Iglesias, Juan F (2021). Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial. JACC. Cardiovascular Interventions, 14(6), pp. 639-648. Elsevier 10.1016/j.jcin.2020.12.011

Iglesias, Juan F; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas (2020). Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial. JACC. Cardiovascular Interventions, 13(19), pp. 2314-2316. Elsevier 10.1016/j.jcin.2020.07.038

Iglesias, Juan F; Heg, Dik; Roffi, Marco; Tüller, David; Lanz, Jonas; Rigamonti, Fabio; Muller, Olivier; Moarof, Igal; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents. Journal of the American Heart Association, 8(22), e013607. American Heart Association 10.1161/JAHA.119.013607

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet, 394(10205), pp. 1243-1253. Elsevier 10.1016/S0140-6736(19)31877-X

Iglesias, Juan F; Heg, Dierik Hans; Roffi, Marco; Tüller, David; Noble, Stéphane; Muller, Olivier; Moarof, Igal; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Häner, Jonas; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial. Circulation: Cardiovascular interventions, 12(8), e008024. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.119.008024

Pilgrim, Thomas; Piccolo, Raffaele; Heg, Dik; Roffi, Marco; Tüller, David; Muller, Olivier; Moarof, Igal; Siontis, George C M; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Hunziker, Lukas; Eberli, Franz R; Jüni, Peter; Windecker, Stephan (2018). Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet, 392(10149), pp. 737-746. Elsevier 10.1016/S0140-6736(18)31715-X

Iglesias, Juan F; Muller, Olivier; Zaugg, Serge; Roffi, Marco; Kurz, David J; Vuilliomenet, André; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Heg, Dik; Valgimigli, Marco; Eeckhout, Eric; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2018). A comparison of an ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. EuroIntervention, 14(6), pp. 692-699. Europa Digital & Publishing 10.4244/EIJ-D-17-00734

Coquoz, Nicolas; Weilenmann, Daniel; Stolz, Daiana; Popov, Vladimir; Azzola, Andrea; Fellrath, Jean-Marc; Stricker, Hans; Pagnamenta, Alberto; Ott, Sebastian; Ulrich, Silvia; Györik, Sandor; Pasquier, Jérôme; Aubert, John-David (2018). Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. European respiratory journal, 51(4) European Respiratory Society 10.1183/13993003.02505-2017

Koskinas, Konstantinos C; Taniwaki, Masanori; Rigamonti, Fabio; Heg, Dik; Roffi, Marco; Tüller, David; Muller, Olivier; Vuillomenet, Andre; Cook, Stephane; Weilenmann, Daniel; Kaiser, Christopher; Jamshidi, Peiman; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2017). Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents. American journal of cardiology, 119(4), pp. 501-507. Elsevier 10.1016/j.amjcard.2016.10.038

Pilgrim, Thomas; Piccolo, Raffaele; Heg, Dik; Roffi, Marco; Tüller, David; Vuilliomenet, André; Muller, Olivier; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Khattab, Ahmed Aziz; Taniwaki, Masanori; Rigamonti, Fabio; Nietlispach, Fabian; Blöchlinger, Stefan; Wenaweser, Peter Martin; Jüni, Peter; Windecker, Stephan (2016). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. EuroIntervention, 12(11), e1343-e1354. Europa Digital & Publishing 10.4244/EIJY15M12_09

Franzone, Anna; Taniwaki, Masanori; Rigamonti, Fabio; Heg, Dik; Piccolo, Raffaele; Roffi, Marco; Tüller, David; Muller, Olivier; Vuilliomenet, Andre; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2016). Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial. EuroIntervention, 12(5), e595-604. Europa Digital & Publishing 10.4244/EIJV12I5A99

Piccolo, Raffaele; Heg, Dik; Franzone, Anna; Roffi, Marco; Tüller, David; Vuilliomenet, André; Muller, Olivier; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Iglesias, Juan F; Windecker, Stephan; Pilgrim, Thomas (2016). Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction: Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial. JACC. Cardiovascular Interventions, 9(9), pp. 981-983. Elsevier 10.1016/j.jcin.2016.02.044

Zbinden, Rainer; Piccolo, Raffaele; Heg, Dik; Roffi, Marco; Kurz, David J; Muller, Olivier; Vuilliomenet, André; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Franzone, Anna; Eberli, Franz; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2016). Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial. Journal of the American Heart Association, 5(3), e003255. American Heart Association 10.1161/JAHA.116.003255

Franzone, Anna; Pilgrim, Thomas; Heg, Dik; Roffi, Marco; Tüller, David; Vuilliomenet, André; Muller, Olivier; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Räber, Lorenz; Stortecky, Stefan; Wenaweser, Peter Martin; Jüni, Peter; Windecker, Stephan (2015). Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Prespecified Subgroup Analysis of the BIOSCIENCE Trial. Circulation: Cardiovascular interventions, 8(6), e002319. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.114.002319

Mueller-Mottet, Séverine; Stricker, Hans; Domenighetti, Guido; Domeninghetti, Guido; Azzola, Andrea; Geiser, Thomas; Schwerzmann, Markus; Weilenmann, Daniel; Schoch, Otto; Fellrath, Jean-Marc; Rochat, Thierry; Lador, Frederic; Beghetti, Maurice; Nicod, Laurent; Aubert, John-David; Popov, Vladimir; Speich, Rudolf; Keusch, Stephan; Hasler, Elisabeth; Huber, Lars C; ... (2015). Long-term data from the Swiss pulmonary hypertension registry. Respiration, 89(2), pp. 127-140. Karger 10.1159/000370125

Pilgrim, Thomas; Heg, Dik; Roffi, Marco; Tüller, David; Muller, Olivier; Vuilliomenet, André; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Fahrni, Therese; Moschovitis, Aris; Noble, Stéphane; Eberli, Franz R; Wenaweser, Peter Martin; Jüni, Peter; Windecker, Stephan (2014). Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial. Lancet, 384(9960), pp. 2111-22. Elsevier 10.1016/S0140-6736(14)61038-2

Pilgrim, Thomas; Roffi, Marco; Tüller, David; Muller, Olivier; Vuillomenet, André; Cook, Stéphane; Weilenmann, Daniel; Kaiser, Christoph; Jamshidi, Peiman; Heg, Dik; Jüni, Peter; Windecker, Stephan (2014). Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: Rationale and design of the BIOSCIENCE trial. American Heart Journal, 168(3), pp. 256-261. Elsevier 10.1016/j.ahj.2014.06.004

Dataset

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain Pierre; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial [Dataset].

This list was generated on Tue Dec 3 18:22:47 2024 CET.
Provide Feedback